Skip to content

Bibliography

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

  • Waddel, G., & Aylward, M. (2005). The Scientific and Conceptual Basis of Incapacity Benefits. The Stationary Office.London.

  • Wade, D. T., & Halligan, P. W. (2004). Do biomedical models of illness make for good healthcare systems? BMJ, 329(7479), 1398-1401.

  • Wade, D. T. (1992). Measurement in neurological rehabilitation Current Opinion in Neurology & Neurosurgery, 5(5), 682-686.

  • Walker, M. F., Sunderland, A., Fletcher-Smith, J., Drummond, A., Logan, P., Edmans, J. A., et al. (2011). The DRESS trial: a feasibility randomized controlled trial of a neuropsychological approach to dressing therapy for stroke inpatients Clinical Rehabilitation, 26, 675-685.

  • Walsh, M. E., Galvin, R., Loughnane, C., Macey, C., & Horgan, N. F. (2015). Factors associated with community reintegration in the first year after stroke: a qualitative meta-synthesis Disability & Rehabilitation, 37(18), 1599-1608.

  • Wang, Y., Wang, Y., Zhao, X., Liu, L., Wang, D., Wang, C., et al. (2013). Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack New England Journal of Medicine, 369(1), 11-19.

  • Wang, T., Dong, L., Cong, X., Luo, H., Li, W., Meng, P., et al. (2021a). Comparative efficacy of non-invasive neurostimulation therapies for poststroke dysphagia: A systematic review and meta-analysis Neurophysiologie Clinique, 51(6), 493-506.

  • Wang, X., Ouyang, M., Yang, J., Song, L., Yang, M., & Anderson, C. S. (2021b). Anticoagulants for acute ischaemic stroke Cochrane Database of Systematic Reviews(10), CD000024.

  • Wang, Y., Meng, X., Wang, A., Xie, X., Pan, Y., Johnston, S. C., et al. (2021c). Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA New England Journal of Medicine.

  • Wang, Y., Li, S., Pan, Y., Li, H., Parsons, M. W., Campbell, B. C. V., et al. (2023). Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial Lancet, 40(10377), P618-619.

  • Ward, A. B., Wissel, J., Borg, J., Ertzgaard, P., Herrmann, C., Kulkarni, J., et al. (2014). Functional goal achievement in post-stroke spasticity patients: the BOTOX Economic Spasticity Trial (BEST) Journal of Rehabilitation Medicine, 46(6), 504-513.

  • Ward, N. S., Brander, F., & Kelly, K. (2019). Intensive upper limb neurorehabilitation in chronic stroke: outcomes from the Queen Square programme Journal of Neurology, Neurosurgery & Psychiatry, 90(5), 498.

  • Wardlaw, J. M., Seymour, J., Cairns, J., Keir, S., Lewis, S., & Sandercock, P. (2004). Immediate computed tomography scanning of acute stroke is cost-effective and improves quality of life Stroke, 35(11), 2477-2483.

  • Wardlaw, J. M., Murray, V., Berge, E., del Zoppo, G., Sandercock, P., Lindley, R. L., et al. (2012). Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis Lancet, 379(9834), 2364-2372.

  • Wardlaw, J., Brazzelli, M., Miranda, H., Chappell, F., McNamee, P., Scotland, G., et al. (2014). An assessment of the cost-effectiveness of magnetic resonance, including diffusion-weighted imaging, in patients with transient ischaemic attack and minor stroke: a systematic review, meta-analysis and economic evaluation Health technology assessment (Winchester, England), 18, 1-6.

  • Warner, G., Packer, T., Villeneuve, M., Audulv, A., & Versnel, J. (2015). A systematic review of the effectiveness of stroke self-management programs for improving function and participation outcomes: self-management programs for stroke survivors Disability & Rehabilitation, 1-23.

  • Watkins, C. L., Auton, M. F., Deans, C. F., Dickinson, H. A., Jack, C. I., Lightbody, C. E., et al. (2007). Motivational interviewing early after acute stroke: a randomized, controlled trial Stroke, 38(3), 1004-1009.

  • Wattchow, K. A., McDonnell, M. N., & Hillier, S. L. (2018). Rehabilitation Interventions for Upper Limb Function in the First Four Weeks Following Stroke: A Systematic Review and Meta-Analysis of the Evidence Arch Phys Med Rehabil, 99(2), 367-382.

  • West, T., & Bernhardt, J. (2012). Physical activity in hospitalised stroke patients Stroke Res Treat, 2012, 813765.

  • West, C., Hesketh, A., Vail, A., & Bowen, A. (2005). Interventions for apraxia of speech following stroke Cochrane Database of Systematic Reviews(4), CD004298.

  • West, C., Bowen, A., Hesketh, A., & Vail, A. (2008). Interventions for motor apraxia following stroke Cochrane Database of Systematic Reviews(1), CD004132.

  • Westendorp, W. F., Vermeij, J. D., Zock, E., Hooijenga, I. J., Kruyt, N. D., Bosboom, H. J., et al. (2015). The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial Lancet, 385(9977), 1519-1526.

  • Westerlind, E., Persson, H. C., Tornbom, K., & Sunnerhagen, K. S. (2020). Return to work predicts perceived participation and autonomy by individuals with stroke Disability and Rehabilitation, 42(25), 3673-3678.

  • White, P. M., Bhalla, A., Dinsmore, J., James, M., McConachie, N., Roffe, C., et al. (2015). Standards for providing safe acute ischaemic stroke thrombectomy (on behalf of the British Association of Stroke Physicians British Society of Neuroradiologists Intercollegiate Stroke Working Party Neuroanaesthesia and Neurocritical Care Society of GB and Ireland, UK Neurointerventional Group) Clin Radiol, 72(2), 175.e171-175.e179.

  • Whiteley, W. N., Slot, K. B., Fernandes, P., Sandercock, P., & Wardlaw, J. (2012). Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies Stroke, 43(11), 2904-2909.

  • Whiteley, W. N., Adams, H. P., Bath, P. M. W., Berge, E., Sandset, P. M., Dennis, M., et al. (2013). Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: An individual patient data meta-analysis of randomised controlled trials The Lancet Neurology, 12(6), 539-545.

  • Whiteley, W. N., MacRaild, A., Wang, Y., Dennis, M., Al-Shahi Salman, R., Gray, A., et al. (2022). Clinical Diagnosis and Magnetic Resonance Imaging in Patients With Transient and Minor Neurological Symptoms: A Prospective Cohort Study Stroke, 53(11), 3419-3428.

  • Wiffen, P. J., Derry, S., Moore, R. A., Aldington, D., Cole, P., Rice, A. S., et al. (2013). Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews Cochrane Database of Systematic Reviews, 11, CD010567.

  • Wikander, B., Ekelund, P., & Milsom, I. (1998). An evaluation of multidisciplinary intervention governed by functional independence measure (FIMSM) in incontinent stroke patients Scandinavian Journal of Rehabilitation Medicine, 30(1), 15-21.

  • Wilkinson, D., Zubko, O., Sakel, M., Coulton, S., Higgins, T., & Pullicino, P. (2014). Galvanic vestibular stimulation in hemi-spatial neglect Frontiers in Integrative Neuroscience, 8(JAN), Article 4.

  • Wilson, R. D., & Howe, E. C. (2012). A cost-effectiveness analysis of screening methods for dysphagia after stroke Pm & R, 4(4), 273-282.

  • Wilson, D., & Werring, D. J. (2017). Antithrombotic therapy in patients with cerebral microbleeds Curr Opin Neurol, 30(1), 38-47.

  • Wilson, D., Ambler, G., Shakeshaft, C., Brown, M. M., Charidimou, A., Al-Shahi Salman, R., et al. (2018). Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study The Lancet Neurology, 17(6), 539-547.

  • Wilson, D., Ambler, G., Lee, K. J., Lim, J. S., Shiozawa, M., Koga, M., et al. (2019). Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies The Lancet Neurology, 18(7), 653-665.

  • Winkens, I., Van Heugten, C. M., Wade, D. T., Habets, E. J., & Fasotti, L. (2009). Efficacy of time pressure management in stroke patients with slowed information processing: a randomized controlled trial Archives of Physical Medicine & Rehabilitation, 90(10), 1672-1679.

  • Wissel, J., Manack, A., & Brainin, M. (2013). Toward an epidemiology of poststroke spasticity Neurology, 80(3 Suppl 2), S13-19.

  • Wolf, S. L., Winstein, C. J., Miller, J. P., Taub, E., Uswatte, G., Morris, D., et al. (2006). Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial JAMA, 296(17), 2095-2104.

  • Wolf, S. L., Kwakkel, G., Bayley, M., & McDonnell, M. N. (2016). Best practice for arm recovery post stroke: an international application Physiotherapy, 102(1), 1-4.

  • World Health Organization. (1978). Cerebrovascular diseases: a clinical and research classification. https://apps.who.int/iris/bitstream/handle/10665/37194/WHO_OFFSET_43.pdf?sequence=1&isAllowed=y

  • Worthington, E., Hawkins, L., Lincoln, N., & Drummond, A. (2017). The day-to-day experiences of people with fatigue after stroke: Results from the Nottingham Fatigue After Stroke study International Journal of Therapy and Rehabilitation, 24(10), 449-455.

  • Wressle, E., Eeg-Olofsson, A. M., Marcusson, J., & Henriksson, C. (2002). Improved client participation in the rehabilitation process using a client-centred goal formulation structure J Rehabil Med, 34(1), 5-11.

  • Wu, S., Mead, G., Macleod, M., & Chalder, T. (2015). Model of understanding fatigue after stroke Stroke, 46(3), 893-898.

  • Wu, J., Cheng, H., Zhang, J., Yang, S., & Cai, S. (2021). Robot-Assisted Therapy for Upper Extremity Motor Impairment After Stroke: A Systematic Review and Meta-Analysis Physical Therapy, 101(4).

Back to top